mibefradil

DRUG2 trials

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Cavion, Inc.

Conditions

Brain and Central Nervous System TumorsHealthy

Phase 1

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

CompletedNCT01480050

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsBrain and Central Nervous System Tumors

Start: 2012-05-31End: 2017-06-01Updated: 2019-05-22

Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers

CompletedNCT01550458

Cavion, Inc.Healthy

Start: 2012-02-29End: 2012-06-24Updated: 2019-04-08

Related Papers

Timed-sequential therapy with mibefradil and temozolomide in patients with recurrent high-grade gliomas: A phase I Adult Brain Tumor Consortium study.

Journal of Clinical Oncology2015-05-20